HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant mothers. HeraMED Limited was founded in 2011 and is based in Camberwell, Australia.
Metrics to compare | HMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHMDPeersSector | |
---|---|---|---|---|
P/E Ratio | −2.6x | −3.0x | −0.5x | |
PEG Ratio | −0.04 | −0.03 | 0.00 | |
Price/Book | 5.1x | 3.0x | 2.6x | |
Price / LTM Sales | 38.5x | 2.4x | 2.9x | |
Upside (Analyst Target) | - | 113.3% | 57.1% | |
Fair Value Upside | Unlock | 15.2% | 9.0% | Unlock |